<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Pharmacological inhibition of cell excitation during focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was studied in the rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model </plain></SENT>
<SENT sid="1" pm="."><plain>The potent and selective <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> <z:chebi fb="68" ids="48706">antagonist</z:chebi> CGS 19755, administered 5 minutes prior to or 5 minutes following permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, caused a substantial decrease in <z:mpath ids='MPATH_124'>infarct</z:mpath> size, which was associated with reduction of postischemic cerebral <z:chebi fb="105" ids="17234">glucose</z:chebi> hypermetabolism </plain></SENT>
<SENT sid="2" pm="."><plain>These data support a role for excitation-induced hypermetabolism in the pathogenesis of infarction following focal <z:e sem="disease" ids="C0596298" disease_type="Disease or Syndrome" abbrv="">cerebrovascular occlusion</z:e> </plain></SENT>
</text></document>